Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2001 Nov;85(5):351–353. doi: 10.1136/adc.85.5.351

Reye syndrome—insights on causation and prognosis

J GLASGOW 1, B MIDDLETON 1
PMCID: PMC1718987  PMID: 11668090

Full Text

The Full Text of this article is available as a PDF (106.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belay E. D., Bresee J. S., Holman R. C., Khan A. S., Shahriari A., Schonberger L. B. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med. 1999 May 6;340(18):1377–1382. doi: 10.1056/NEJM199905063401801. [DOI] [PubMed] [Google Scholar]
  2. Boss O., Hagen T., Lowell B. B. Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes. 2000 Feb;49(2):143–156. doi: 10.2337/diabetes.49.2.143. [DOI] [PubMed] [Google Scholar]
  3. Casteels-Van Daele M. Reye syndrome or side-effects of anti-emetics? Eur J Pediatr. 1991 May;150(7):456–459. doi: 10.1007/BF01958420. [DOI] [PubMed] [Google Scholar]
  4. Chan T. A., Morin P. J., Vogelstein B., Kinzler K. W. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):681–686. doi: 10.1073/pnas.95.2.681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cooperstock M. S., Tucker R. P., Baublis J. V. Possible pathogenic role of endotoxin in Reye's syndrome. Lancet. 1975 Jun 7;1(7919):1272–1274. doi: 10.1016/s0140-6736(75)92553-2. [DOI] [PubMed] [Google Scholar]
  6. Forsyth B. W., Horwitz R. I., Acampora D., Shapiro E. D., Viscoli C. M., Feinstein A. R., Henner R., Holabird N. B., Jones B. A., Karabelas A. D. New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association. JAMA. 1989 May 5;261(17):2517–2524. [PubMed] [Google Scholar]
  7. Glasgow J. F., Middleton B., Moore R., Gray A., Hill J. The mechanism of inhibition of beta-oxidation by aspirin metabolites in skin fibroblasts from Reye's syndrome patients and controls. Biochim Biophys Acta. 1999 May 31;1454(1):115–125. doi: 10.1016/s0925-4439(99)00025-3. [DOI] [PubMed] [Google Scholar]
  8. Halestrap A. P. The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury. Biochem Soc Symp. 1999;66:181–203. doi: 10.1042/bss0660181. [DOI] [PubMed] [Google Scholar]
  9. Hall S. M. Reye's syndrome and aspirin: a review. Br J Clin Pract Suppl. 1990 Aug;70:4–11. [PubMed] [Google Scholar]
  10. Hardie R. M., Newton L. H., Bruce J. C., Glasgow J. F., Mowat A. P., Stephenson J. B., Hall S. M. The changing clinical pattern of Reye's syndrome 1982-1990. Arch Dis Child. 1996 May;74(5):400–405. doi: 10.1136/adc.74.5.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Herbein G., O'Brien W. A. Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proc Soc Exp Biol Med. 2000 Mar;223(3):241–257. doi: 10.1177/153537020022300305. [DOI] [PubMed] [Google Scholar]
  12. Larrick J. W., Kunkel S. L. Is Reye's syndrome caused by augmented release of tumour necrosis factor? Lancet. 1986 Jul 19;2(8499):132–133. doi: 10.1016/s0140-6736(86)91947-1. [DOI] [PubMed] [Google Scholar]
  13. Maddaiah V. T., Miller P. S. Effects of ammonium chloride, salicylate, and carnitine on palmitic acid oxidation in rat liver slices. Pediatr Res. 1989 Feb;25(2):119–123. doi: 10.1203/00006450-198902000-00003. [DOI] [PubMed] [Google Scholar]
  14. Meekin S. L., Glasgow J. F., McCusker C. G., Rooney N. A long-term follow-up of cognitive, emotional, and behavioural sequelae to Reye syndrome. Dev Med Child Neurol. 1999 Aug;41(8):549–553. doi: 10.1017/s0012162299001164. [DOI] [PubMed] [Google Scholar]
  15. Meert K. L., Kauffman R. E., Deshmukh D. R., Sarnaik A. P. Impaired oxidative metabolism of salicylate in Reye's syndrome. Dev Pharmacol Ther. 1990;15(2):57–60. doi: 10.1159/000457622. [DOI] [PubMed] [Google Scholar]
  16. Monto A. S. The disappearance of Reye's syndrome--a public health triumph. N Engl J Med. 1999 May 6;340(18):1423–1424. doi: 10.1056/NEJM199905063401809. [DOI] [PubMed] [Google Scholar]
  17. Orlowski J. P. Whatever happened to Reye's syndrome? Did it ever really exist? Crit Care Med. 1999 Aug;27(8):1582–1587. doi: 10.1097/00003246-199908000-00032. [DOI] [PubMed] [Google Scholar]
  18. Paumen M. B., Ishida Y., Muramatsu M., Yamamoto M., Honjo T. Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. J Biol Chem. 1997 Feb 7;272(6):3324–3329. doi: 10.1074/jbc.272.6.3324. [DOI] [PubMed] [Google Scholar]
  19. Pessayre D., Mansouri A., Haouzi D., Fromenty B. Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol. 1999;15(6):367–373. doi: 10.1023/a:1007649815992. [DOI] [PubMed] [Google Scholar]
  20. Ricquier D., Bouillaud F. The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. Biochem J. 2000 Jan 15;345(Pt 2):161–179. [PMC free article] [PubMed] [Google Scholar]
  21. Soumerai S. B., Ross-Degnan D., Kahn J. S. Effects of professional and media warnings about the association between aspirin use in children and Reye's syndrome. Milbank Q. 1992;70(1):155–182. [PubMed] [Google Scholar]
  22. Trost L. C., Lemasters J. J. Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye's syndrome. Toxicol Appl Pharmacol. 1997 Dec;147(2):431–441. doi: 10.1006/taap.1997.8313. [DOI] [PubMed] [Google Scholar]
  23. Trost L. C., Lemasters J. J. The mitochondrial permeability transition: a new pathophysiological mechanism for Reye's syndrome and toxic liver injury. J Pharmacol Exp Ther. 1996 Sep;278(3):1000–1005. [PubMed] [Google Scholar]
  24. Yin M. J., Yamamoto Y., Gaynor R. B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature. 1998 Nov 5;396(6706):77–80. doi: 10.1038/23948. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES